ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 71 filers reported holding ATHIRA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,000 | -25.0% | 10,000 | -24.7% | 0.01% | -12.5% |
| Q2 2022 | $40,000 | -79.5% | 13,275 | -8.3% | 0.01% | -74.2% |
| Q1 2022 | $195,000 | +3.7% | 14,475 | +0.3% | 0.03% | +10.7% |
| Q4 2021 | $188,000 | +35.3% | 14,425 | -2.5% | 0.03% | +27.3% |
| Q3 2021 | $139,000 | -9.7% | 14,800 | -1.3% | 0.02% | -8.3% |
| Q2 2021 | $154,000 | – | 15,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |